Details for New Drug Application (NDA): 210918
✉ Email this page to a colleague
The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.
Summary for 210918
Tradename: | ISOSORBIDE MONONITRATE |
Applicant: | Riconpharma Llc |
Ingredient: | isosorbide mononitrate |
Patents: | 0 |
Pharmacology for NDA: 210918
Physiological Effect | Vasodilation |
Suppliers and Packaging for NDA: 210918
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 210918 | ANDA | A-S Medication Solutions | 50090-5686 | 50090-5686-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5686-0) |
ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 210918 | ANDA | A-S Medication Solutions | 50090-5686 | 50090-5686-1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5686-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
Approval Date: | Nov 5, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 60MG | ||||
Approval Date: | Nov 5, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 120MG | ||||
Approval Date: | Nov 5, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription